Skip to main content

Peer Review reports

From: Efficacy and safety of chemotherapy as monotherapy in patients with recurrent intermediate/high-risk factors following radical hysterectomy for stage IB-IIA cervical cancer: a single-center retrospective analysis

Original Submission
16 Nov 2023 Submitted Original manuscript
15 Mar 2024 Reviewed Reviewer Report
18 Mar 2024 Reviewed Reviewer Report
20 Mar 2024 Reviewed Reviewer Report
21 Mar 2024 Reviewed Reviewer Report
25 Apr 2024 Author responded Author comments - Su-Fang Zhou
Resubmission - Version 2
25 Apr 2024 Submitted Manuscript version 2
26 Apr 2024 Author responded Author comments - Su-Fang Zhou
Resubmission - Version 3
26 Apr 2024 Submitted Manuscript version 3
28 Apr 2024 Reviewed Reviewer Report - Ruifang Chen
29 Apr 2024 Reviewed Reviewer Report
6 May 2024 Author responded Author comments - Su-Fang Zhou
Resubmission - Version 4
6 May 2024 Submitted Manuscript version 4
Publishing
7 May 2024 Editorially accepted
18 May 2024 Article published 10.1186/s12905-024-03135-7

You can find further information about peer review here.

Back to article page